Marathon Trading Investment Management’s Clover Health Investments CLOV Stock Holding History

Marathon Trading Investment Management’s Portfolio CLOV Stock Details CLOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$57.6K	Hold	11,000	–	–	﹤0.01%	228
2026 Q1	$19.4K	Hold	11,000	–	–	﹤0.01%	253
2025 Q4	$25.9K	Hold	11,000	–	–	﹤0.01%	291
2025 Q3	$33.7K	Hold	11,000	–	–	﹤0.01%	252
2025 Q2	$30.7K	Sell	11,000 -2,000	-15%	-$6.58K	﹤0.01%	245
2025 Q1	$46.7K	Hold	13,000	–	–	0.01%	304
2024 Q4	$41K	Sell	13,000 -495	-4%	-$1.77K	﹤0.01%	270
2024 Q3	$38.1K	Hold	13,495	–	–	﹤0.01%	245
2024 Q2	$16.6K	Hold	13,495	–	–	﹤0.01%	268
2024 Q1	$10.7K	Hold	13,495	–	–	﹤0.01%	326
2023 Q4	$12.8K	Hold	13,495	–	–	﹤0.01%	340
2023 Q3	$14.6K	Hold	13,495	–	–	﹤0.01%	295
2023 Q2	$12.1K	Hold	13,495	–	–	﹤0.01%	242
2023 Q1	$11.4K	Buy	+13,495	New	+$14.8K	﹤0.01%	243
2022 Q1	–	Sell	-32,495	Closed	-$121K	–	326
2021 Q4	$121K	Sell	32,495 -6,000	-16%	-$36.8K	0.01%	251
2021 Q3	$284K	Sell	38,495 -38,500	-50%	-$329K	0.02%	269
2021 Q2	$1.02M	Sell	76,995 -13,700	-15%	-$135K	0.1%	115
2021 Q1	$685K	Buy	+90,695	New	+$1.02M	0.06%	172

Other funds holding CLOV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Marathon Trading Investment Management's CLOV Position: Q2 2026 in Review

Marathon Trading Investment Management held its Clover Health Investments (CLOV) position steady in Q2 2026 at 11,000 shares worth $57.6K. The position accounts for ﹤0.01% of the portfolio, ranked #228.

Marathon Trading Investment Management first reported a position in CLOV in Q1 2021 and has held it in 18 quarters since. The position peaked at $1.02M in Q2 2021. 227 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

Marathon Trading Investment Management held 11,000 shares of Clover Health Investments worth $57.6K as of Q2 2026.
Marathon Trading Investment Management left its Clover Health Investments share count unchanged in Q2 2026.
Clover Health Investments made up ﹤0.01% of Marathon Trading Investment Management's portfolio in Q2 2026, its #228 holding.
Marathon Trading Investment Management first reported a position in Clover Health Investments in Q1 2021 and has held it in 18 quarters since.
Marathon Trading Investment Management's Clover Health Investments position peaked at $1.02M in Q2 2021.
227 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on Marathon Trading Investment Management's 13F filing for Q2 2026, filed 12 Aug 2026.